Tamar R. Lubell

Tamar R. Lubell

Auto-generated profile, based on publicly available information

Tamar R. Lubell

Department of Emergency Medicine, Division of Pediatric Emergency Medicine Columbia University Vagelos College of Physicians and Surgeons New York New York USA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2017 in Pediatrics
Verified
Journal Article
Closed access
PDF file
TLTamar R. Lubell
Tamar R. Lubell
JBJonathan M. Barasch
Jonathan M. Barasch
KXKatherine Xu
Katherine Xu
MIMaria Ieni
Maria Ieni
KCKeven I. Cabrera
Keven I. Cabrera
PDPeter S. Dayan
Peter S. Dayan
OBJECTIVES: To determine the accuracy of the novel biomarker urinary neutrophil gelatinase–associated lipocalin (uNGAL) to diagnose urinary tract infections (UTIs) in febrile infants and young children. METHODS: Prospective cross-sectional study of febrile infants <3 months ( ≥ 38.0°C) and children 3 to 24 months (≥ 39.0°C) evaluated for UTIs. uNGAL levels, urinalysis, Gram-stain and culture were obtained. UTI was defined by colony counts. RESULTS: Of 260 patients, 35 (13.5%) had UTIs. Median uNGAL levels were 215.1 ng/mL (interquartile range: 100.3–917.8) and 4.4 ng/mL (interquartile range: 1.6–11.8) in the groups diagnosed with and without UTIs, respectively. The area under the receiver-operating characteristic curve for uNGAL was 0.978 (95% confidence interval [CI]: 0.948–1.000). At a threshold uNGAL level of 39.1 ng/mL, sensitivity was 97.1% (95% CI: 83.4–99.9) and specificity was 95.6% (95% CI: 91.7–97.7). uNGAL had higher sensitivity than the combination of leukocyte esterase (in trace or greater amounts) or nitrite (+) (97.1%, 95% CI: 83.4–99.9 vs 74.3%, 95% CI: 56.4–86.9), with similar specificity (95.6%, 95% CI: 91.7–97.7 vs 97.3%, 95% CI: 94.0–98.9). uNGAL had higher sensitivity than Gram-stain (97.1%, 95% CI: 83.4–99.9 vs 74.3%, 95%: CI: 56.4–86.9), with similar specificity (95.6%, 95% CI: 91.7–97.7 vs 100.0%, 95% CI: 97.9–100.0). CONCLUSIONS: uNGAL has substantial accuracy to identify those with and without UTIs in infants and young children. Further studies will need to confirm our findings and determine if uNGAL is a more cost-effective test than standard screening tests.

22 October 2021 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Open access
JHJanice Jing Huang
Janice Jing Huang
SGSamantha B. Gaines
Samantha B. Gaines
MAMateo L. Amezcua
Mateo L. Amezcua
TLTamar R. Lubell
Tamar R. Lubell
PDPeter S. Dayan
Peter S. Dayan
MGMark Gorelik
Mark Gorelik
Multisystem inflammatory syndrome in children (MIS-C) is an acute, febrile, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-associated syndrome, often with cardiohemodynamic dysfunction. Insight into mechanism of disease is still incomplete. Our objective was to analyze immunologic features of MIS-C patients compared to febrile controls (FC). MIS-C patients were defined by narrow criteria, including having evidence of cardiohemodynamic involvement and no macrophage activation syndrome. Samples were collected from 8 completely treatment-naive patients with MIS-C (SARS-CoV-2 serology positive), 3 patients with unclassified MIS-C–like disease (serology negative), 14 FC, and 5 MIS-C recovery (RCV). Three healthy controls (HCs) were used for comparisons of normal range. Using spectral flow cytometry, we assessed 36 parameters in antigen-presenting cells (APCs) and 29 in T cells. We used biaxial analysis and uniform manifold approximation and projection (UMAP). Significant elevations in cytokines including CXCL9, M-CSF, and IL-27 were found in MIS-C compared to FC. Classic monocytes and type 2 dendritic cells (DCs) were downregulated (decreased CD86, HLA-DR) versus HCs; however, type 1 DCs (CD11c+CD141+CLEC9A+) were highly activated in MIS-C patients versus FC, expressing higher levels of CD86, CD275, and atypical conventional DC markers such as CD64, CD115, and CX3CR1. CD169 and CD38 were upregulated in multiple monocyte subtypes. CD56dim/CD57−/KLRGhi/CD161+/CD38− natural killer (NK) cells were a unique subset in MIS-C versus FC without macrophage activation syndrome. Orchestrated by complex cytokine signaling, type 1 DC activation and NK dysregulation are key features in the pathophysiology of MIS-C. NK cell findings may suggest a relationship with macrophage activation syndrome, while type 1 DC upregulation implies a role for antigen cross-presentation.

25 November 2021 in Academic Emergency Medicine
Verified
Journal Article
Closed access
PDF file
DTDaniel Tsze
Daniel Tsze
TLTamar R. Lubell
Tamar R. Lubell
RCRobert C. Carter
Robert C. Carter
LCLauren S. Chernick
Lauren S. Chernick
KDKerrin C. DePeter
Kerrin C. DePeter
PDPeter S. Dayan
Peter S. Dayan

9 November 2021 in Academic Emergency Medicine
Verified
Journal Article
Closed access
PDF file
TLTamar R. Lubell
Tamar R. Lubell
JBJonathan M. Barasch
Jonathan M. Barasch
BKBenjamin King
Benjamin King
JOJulie B. Ochs
Julie B. Ochs
WFWeijia Fan
Weijia Fan
PDPeter S. Dayan
Peter S. Dayan

1 July 2023 in Pediatric Emergency Care
Verified
Journal Article
Closed access
TLTamar R. Lubell
Tamar R. Lubell
MGMark Gorelik
Mark Gorelik
DADori Abel
Dori Abel
AFAvital M. Fischer
Avital M. Fischer
GAGabriel Apfel
Gabriel Apfel
PDPeter S. Dayan
Peter S. Dayan
Objectives: The case definition for multisystem inflammatory syndrome in children (MIS-C) is broad and encompasses symptoms and signs commonly seen in children with fever. Our aim was to identify clinical predictors that, independently or in combination, identify febrile children presenting to the emergency department (ED) as low risk for MIS-C. Methods: We conducted a retrospective single-center study of otherwise healthy children 2 months to 20 years of age presenting to the ED with fever and who had a laboratory evaluation for MIS-C between April 15, 2020, and October 31, 2020. We excluded children with a diagnosis of Kawasaki disease. Our outcome was an MIS-C diagnosis defined by the Centers for Disease Control and Prevention criteria. We conducted multivariable logistic regression analyses to identify variables independently associated with MIS-C. Results: Thirty-three patients with and 128 patients without MIS-C were analyzed. Of those with MIS-C, 16 of 33 (48.5%) had hypotension for age, signs of hypoperfusion, or required ionotropic support. Four variables were independently associated with the presence of MIS-C; known or suspected SARS CoV-2 exposure (adjusted odds ratio [aOR], 4.0; 95% confidence interval [CI], 1.4–11.9) and the following 3 symptoms and signs: abdominal pain on history (aOR, 4.8; 95% CI, 1.7–15.0), conjunctival injection (aOR, 15.2; 95% CI, 5.4–48.1), and rash involving the palms or soles (aOR, 12.2; 95% CI, 2.4–69.4). Children were at low risk of MIS-C if none of the 3 symptoms or signs were present (sensitivity 87.9% [95% CI, 71.8–96.6]; specificity 62.5% [53.5–70.9], negative predictive value 95.2% [88.3–98.7]). Of the 4 MIS-C patients without any of these 3 factors, 2 were ill-appearing in the ED and the other 2 had no cardiovascular involvement during their clinical course. Conclusions: A combination of 3 clinical symptoms and signs had moderate to high sensitivity and high negative predictive value for identifying febrile children at low risk of MIS-C. If validated, these factors could aid clinicians in determining the need to obtain or forego an MIS-C laboratory evaluation during SARS-CoV-2 prevalent periods in febrile children.

6 April 2023 in The Pediatric Infectious Disease Journal
Verified
Journal Article
Closed access
TLTamar R. Lubell
Tamar R. Lubell
ACAndrea T. Cruz
Andrea T. Cruz
MTMelisa S. Tanverdi
Melisa S. Tanverdi
JOJulie B. Ba Ochs
Julie B. Ba Ochs
SLSteven Lobritto
Steven Lobritto
PDPeter S. Md Dayan
Peter S. Md Dayan
Background: We aimed to determine the frequency of bacteremia, septic shock and bacterial meningitis in pediatric liver transplant recipients (pLTRs) in the outpatient setting and to identify clinical factors associated with bacteremia. Methods: Multicenter retrospective study of pLTRs evaluated in the emergency department or outpatient clinic between 2010 and 2018 for suspected infection, defined as fever ≥38 °C or a blood culture obtained. We excluded patients with nontransplant immunodeficiency, multiorgan transplants or intestinal failure. The primary outcome was bacteremia; secondary outcomes included fluid-refractory septic shock, bacterial meningitis and antibiotic resistance. The unit of analysis was the encounter. Results: A total of 151 children had 336 encounters for infection evaluation within 2 years of transplant. Of 307 (91.4%) encounters with blood cultures, 17 (5.5%) had bacteremia, with 10 (58.8%) occurring within 3 months of transplant. Fluid-refractory septic shock and bacterial meningitis occurred in 7 of 307 (2.8%) and 0 of 307 encounters, respectively. Factors associated with bacteremia included closer proximity to transplant (<3 months) [odds ratio (OR): 3.6; 95% confidence interval (CI): 1.3–9.8; P = 0.01], shorter duration of illness (OR: 4.3; 95% CI: 1.5–12.0; P < 0.01) and the presence of a central venous catheter (CVC) (OR: 12.7; 95% CI: 4.4–36.6; P < 0.01). However, 5 (29.4%) encounters with bacteremia had none of these factors. Among Gram-positive pathogens, 1 of 7 (14.2%) isolates were resistant to vancomycin. Among Gram-negative pathogens, 3 of 13 (23.1%) isolates were resistant to 3rd generation cephalosporins. Conclusions: Bacteremia was an important cause of infection within 2 years of pLTR. Clinical factors increased the risk of bacteremia. Further, large sample studies should derive multivariable models to identify those at high and low risk of bacteremia to optimize antibiotic use.